Apyx Medical (APYX) Raw Materials (2016 - 2018)

Apyx Medical (APYX) has reported Raw Materials for 3 consecutive years, with $4.5 million the latest figure, recorded in Q4 2018.

• For the quarter ending Q4 2018, Raw Materials fell 12.43% year-over-year to $4.5 million; the trailing twelve-month figure through Dec 2018 stood at $4.5 million (down 12.43% YoY), and the FY2018 full-year result was $4.5 million, down 12.43% from the prior year.
• Raw Materials retreated to $4.5 million in Q4 2018 per APYX's latest filing, from $5.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $5.2 million in Q4 2017 and bottomed at $4.5 million in Q4 2016.
• Historically, Raw Materials has averaged $4.7 million across 3 years, with a median of $4.5 million in 2016.
• The sharpest annual moves came in 2017 and 2018: Raw Materials rose 14.2% in 2017, then slipped 12.43% in 2018.
• Over 3 years, Raw Materials stood at $4.5 million in 2016, then advanced by 14.2% to $5.2 million in 2017, then decreased by 12.43% to $4.5 million in 2018.
• According to Business Quant data, Raw Materials over the past three periods registered $4.5 million, $5.2 million, and $4.5 million for Q4 2018, Q4 2017, and Q4 2016 respectively.